Kemerovo Regional Clinical Hospital
Kemerovo 650066
0 studies enrolling now · 17 studies all time
What they study most
Ankylosing Spondyloarthritis, Chronic Kidney Disease, Chronic Lymphocytic Leukemia, Diabetic Foot Ulcers, Diabetic Retinopathy, Hemophilia A, Congenital, Lymphoma, Non-Hodgkin, Multiple Sclerosis, Myeloid Leukemia, Chronic, Chronic Phase, Non-diabetic Chronic Kidney Disease, Relapsing Multiple Sclerosis, Rheumatoid Arthritis
Studies at this site
- Ponatinib in Participants With Resistant Chronic Phase Chronic Myeloid Leukemia (CP-CML) to Characterize the Efficacy and Safety of a Range of Doses — Completed
- A Trial to Learn How Well Finerenone Works and How Safe it is in Adult Participants With Non-diabetic Chronic Kidney Disease — Completed
- Study of Copanlisib in Combination With Standard Immunochemotherapy in Relapsed Indolent Non-Hodgkin's Lymphoma (iNHL) — Stopped early
- Study Comparing Doses Of An Experimental Glucocorticoid Compound To Prednisone And Placebo In Rheumatoid Arthritis — Completed
- A Study of Ocrelizumab in Comparison With Interferon Beta-1a (Rebif) in Participants With Relapsing Multiple Sclerosis — Completed
- A Study to Evaluate the Benefit of Venetoclax Plus Rituximab Compared With Bendamustine Plus Rituximab in Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL) — Completed
- An add-on Study to the FIGARO-DKD Study Called FIGARO-BM to Learn About the Link Between Biomarkers (Substances in the Blood Used as Indicators of Biological Processes, Disease Processes or Responses to Medication) and Finerenone in FIGARO-DKD Participants — Completed
- A Study That Uses Data From Routine Eye Examinations of Patients Participating in Studies FIDELIO-DKD and FIGARO-DKD to Explore Whether Finerenone Can Delay the Progression of a Diabetes Complication That Affects the Eyes (Diabetic Retinopathy ,DR) — Completed
- Alphanate in Immune Tolerance Induction Therapy — Stopped early
- Study of Ozanimod (RPC1063) in Relapsing Multiple Sclerosis (MS) — Completed
- Study of Apremilast to Treat Subjects With Active Ankylosing Spondylitis — Completed
- Attainment of Person-centred Goals After Botulinum Toxin Treatment for Upper Limb Spasticity in Real Life Practice — Completed
- Efficacy and Safety Study of DiaPep277 in Newly Diagnosed Type 1 Diabetes Adults — Completed
- Ranolazine When Added to Glimepiride in Subjects With Type 2 Diabetes Mellitus — Completed
- Ranolazine Monotherapy in Subjects With Type 2 Diabetes Mellitus — Completed
- A Phase 3 Study of Ranolazine in Subjects With Type 2 Diabetes Who Are Inadequately Controlled on Metformin Alone — Completed
- A Study to Investigate the Safety and Clinical Effect of Nexagon® as a Topical Treatment for Subjects With a Diabetic Foot Ulcer (DUNE) — Completed